Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Dermatology | Family Medicine | Infections and Infectious Diseases | Podiatry

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Mentax (1% butenafine HCl cream)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Penederm
Approval Status: Approved December 1997
Treatment Area: athlete's foot

General Information

A one-week dosing regimen for Mentax has been approved for the treatment of athlete's foot. The dosing regimen allows topical application either twice-a-day for seven days, or once-a-day for four weeks for more severe cases of the fungus. Mentax is the only topical antifungal product approved in the U.S. which has such a one-week dosing regimen.